Critical Comparison: Pheton (NASDAQ:PTHL) and AMN Healthcare Services (NYSE:AMN)

AMN Healthcare Services (NYSE:AMN) and Pheton (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Valuation and Earnings

This table compares AMN Healthcare Services and Pheton”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.98 billion	0.24	-$146.98 million	($7.19)	-2.60
Pheton	$305,215.00	13.13	-$660,000.00	N/A	N/A

Pheton has lower revenue, but higher earnings than AMN Healthcare Services.

Profitability

This table compares AMN Healthcare Services and Pheton’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-10.14%	10.89%	3.18%
Pheton	N/A	N/A	N/A

Volatility and Risk

AMN Healthcare Services has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Pheton has a beta of 5.4, indicating that its stock price is 440% more volatile than the S&P 500.

Insider and Institutional Ownership

99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for AMN Healthcare Services and Pheton, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2	2	5	0	2.33
Pheton	1	0	0	0	1.00

AMN Healthcare Services presently has a consensus price target of $22.36, suggesting a potential upside of 19.53%. Given AMN Healthcare Services’ stronger consensus rating and higher probable upside, equities research analysts clearly believe AMN Healthcare Services is more favorable than Pheton.

Summary

AMN Healthcare Services beats Pheton on 8 of the 12 factors compared between the two stocks.

About AMN Healthcare Services

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.